Alphabet financials
$337.32−0.54%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $119.80B | $109.90B | $113.83B | $102.35B | $96.43B | $90.23B | $96.47B | $88.27B | $84.74B | $80.54B | $86.31B | $76.69B |
| Gross profit | $73.85B | $68.63B | $68.06B | $60.98B | $57.39B | $53.87B | $55.86B | $51.79B | $49.23B | $46.83B | $48.73B | $43.46B |
| Gross margin | 61.6% | 62.4% | 59.8% | 59.6% | 59.5% | 59.7% | 57.9% | 58.7% | 58.1% | 58.1% | 56.5% | 56.7% |
| Operating income | $40.77B | $39.70B | $35.93B | $31.23B | $31.27B | $30.61B | $30.97B | $28.52B | $27.43B | $25.47B | $23.70B | $21.34B |
| Net income | $112.11B | $62.58B | $34.45B | $34.98B | $28.20B | $34.54B | $26.54B | $26.30B | $23.62B | $23.66B | $20.69B | $19.69B |
| Net margin | 93.6% | 56.9% | 30.3% | 34.2% | 29.2% | 38.3% | 27.5% | 29.8% | 27.9% | 29.4% | 24.0% | 25.7% |
| Diluted EPS | $9.11 | $5.11 | $2.82 | $2.87 | $2.31 | $2.81 | $2.15 | $2.12 | $1.89 | $1.89 | $1.76 | $1.55 |
| EBITDA | $47.87B | $46.18B | $41.97B | $36.84B | $36.27B | $35.09B | $35.18B | $32.51B | $31.13B | $28.89B | $23.70B | $24.51B |
| Operating cash flow | $39.07B | $45.79B | $52.40B | $48.41B | $27.75B | $36.15B | $39.11B | $30.70B | $26.64B | $28.85B | $18.91B | $30.66B |
| Free cash flow | -$5.86B | $10.12B | $24.55B | $24.46B | $5.30B | $18.95B | $24.84B | $17.64B | $13.45B | $16.84B | $7.90B | $22.60B |
| Diluted shares | 12,309.0M | 12,238.0M | 12,228.0M | 12,203.0M | 12,198.0M | 12,291.0M | 12,347.0M | 12,419.0M | 12,495.0M | 12,527.0M | 11,722.0M | 12,696.0M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $55.91B | $38.06B | $30.71B | $23.09B | $21.04B | $23.26B |
| Short-term investments | $186.56B | $88.78B | $96.14B | $75.41B | $74.11B | $72.06B |
| Total debt | $98.17B | $77.50B | $46.55B | $21.61B | $23.61B | $10.89B |
| Total assets | $921.98B | $703.92B | $595.28B | $536.47B | $502.05B | $475.37B |
| Total liabilities | $281.50B | $225.17B | $180.02B | $149.60B | $139.14B | $130.11B |
| Shareholders' equity | $640.48B | $478.75B | $415.26B | $386.87B | $362.92B | $345.27B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology